Hint mode is switched on Switch off
For swift navigation between sections

Abattis Bioceuticals
LEI 5493000GEXZZJ997G829

Organization name
Abattis Bioceuticals Corp.
Country name
Canada
Country of registration
Canada
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Abattis Bioceuticals Corp. is a specialty life sciences and biotechnology company. Through its operations and wholly owned subsidiaries, the Company has a broad range of capabilities including cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • LEI
    5493000GEXZZJ997G829
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001515768
  • Business number (BN)
    882965775
Registration is required to get access.